Skip to main content
. 2024 Apr 2;14:7709. doi: 10.1038/s41598-024-57645-3

Figure 3.

Figure 3

Baseline fold changes in systemic soluble mediators in adults following 17DD-YF 1/5 fractional dose primary vaccination. Systemic soluble mediators were measured in plasma samples from all volunteers before [NV(D0), n = 15] and 30–45 days after [PV(D30–45), n = 15] 17DD-YF 1/5 fractional dose primary vaccination. Measurements were carried out by xMAP technology as described in “Methods” section. The baseline fold change in the levels of each soluble mediator was calculated for individual samples as the ratio between values, expressed in pg/mL or MFI (#), observed at PV(D30–45) divided by those detected at NV(D0). The baseline fold change values were highlighted by shades of green to represent decreased (≥ 0.5 and ≤ 0.80/Inline graphic or > 0.80 and < 1/Inline graphic) and red to underscore increased values (> 1 and ≤ 1.50/Inline graphic or > 1.50/Inline graphic) baseline fold change values. Unaltered levels (baseline fold change = 1.0) are represented by gray color (Inline graphic) and missing data by white color (▭). (A) A panoramic dashboard was constructed to calculate the median value for each soluble mediator further organized in ascendant manner. (B) Scattering of individual values over bar charts underscore the decreased (shades of green), unaltered (gray) and increased (shades of red) median baseline fold change values. Dashed lines indicate the cut-offs employed to classify values according to distinct color shades (0.8, 1.0 and 1.5).